Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole
- PMID: 2176687
Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole
Abstract
A simple procedure has been developed for isolating a microsomal fraction from Aspergillus fumigatus which contains cytochrome P-450. Maximum absorbance of the carbon monoxide/ferrous cytochrome P-450 difference spectrum was at a wavelength of 451 nm. The triazole antifungal agents, fluconazole and itraconazole, produced type II binding difference spectra with ferric cytochrome P-450 in A. fumigatus microsomes and an azole concentration of 0.5 microM was sufficient to saturate the spectroscopic response when the cytochrome P-450 concentration was 0.07 microM. This extremely high affinity binding precluded the determination of apparent dissociation constants for the cytochrome P-450-azole complexes. Itraconazole was found to have a marginally greater affinity for cytochrome P-450 than fluconazole, as determined from a comparison of their potential to reduce the rate of binding of carbon monoxide to the ferrous haemoprotein. The high affinity binding of both compounds to the cytochrome P-450 from A. fumigatus is consistent with their proposed antifungal mode of action through inhibition of the sterol 14 alpha-demethylase cytochrome P-450 required for ergosterol biosynthesis.
Similar articles
-
Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.J Med Vet Mycol. 1997 Jan-Feb;35(1):19-25. J Med Vet Mycol. 1997. PMID: 9061581
-
A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.J Med Vet Mycol. 1990;28(4):335-44. J Med Vet Mycol. 1990. PMID: 2176688
-
In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei.J Antimicrob Chemother. 1997 Jun;39(6):731-6. doi: 10.1093/jac/39.6.731. J Antimicrob Chemother. 1997. PMID: 9222042
-
Mechanisms of resistance to azole antifungals.Acta Biochim Pol. 1995;42(4):509-16. Acta Biochim Pol. 1995. PMID: 8852341 Review.
-
Biochemical approaches to selective antifungal activity. Focus on azole antifungals.Mycoses. 1989;32 Suppl 1:35-52. doi: 10.1111/j.1439-0507.1989.tb02293.x. Mycoses. 1989. PMID: 2561184 Review.
Cited by
-
Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae.Antimicrob Agents Chemother. 2006 Nov;50(11):3917-9. doi: 10.1128/AAC.00747-06. Epub 2006 Sep 11. Antimicrob Agents Chemother. 2006. PMID: 16966400 Free PMC article.
-
Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance.Antimicrob Agents Chemother. 1996 Nov;40(11):2443-6. doi: 10.1128/AAC.40.11.2443. Antimicrob Agents Chemother. 1996. PMID: 8913443 Free PMC article.
-
Study on the hyphal responses of Aspergillus fumigatus to the antifungal agent by Bio-Cell Tracer.Mycopathologia. 1999;148(1):17-23. doi: 10.1023/a:1007199826225. Mycopathologia. 1999. PMID: 11086481
-
Mutations in hmg1, Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus.mBio. 2019 Apr 2;10(2):e00437-19. doi: 10.1128/mBio.00437-19. mBio. 2019. PMID: 30940706 Free PMC article.
-
Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.Antimicrob Agents Chemother. 1996 Jun;40(6):1382-6. doi: 10.1128/AAC.40.6.1382. Antimicrob Agents Chemother. 1996. PMID: 8726005 Free PMC article.